Find clinical trials for Asthma in Sevilla, AN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Asthma trials near Sevilla, AN, ESP:
This is a study designed to evaluate efficacy and safety of Tezepelumab in reducing oral corticosteroid use in adult patients with severe asthma...
Phase 3
Sevilla, Spain and 76 other locations
and safety with subcutaneous immunotherapy in patients with mild to moderate rhinitis / rhinoconjunctivitis with or without mild to moderate asthma...
Phase 3
Sevilla, Spain and 25 other locations
and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...
Phase 2
Jerez de la Frontera, Spain and 369 other locations
of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...
Phase 3
Jerez de la Frontera, Spain and 429 other locations
in patients with rhinitis/rhinoconjunctivitis with mild to moderate asthma, sensitised to Dermatophagoides pteronyssinus and /or Dermatophag...
Phase 3
Jerez De La Frontera, Spain and 17 other locations
profile of GSK3511294 (Depemokimab) in participants with severe asthma with an eosinophilic phenotype following completion of clinical studi...
Phase 3
Jerez de la Frontera, Spain and 130 other locations
The purpose of this study is to evaluate the efficacy and safety of CHF6001 (Tanimilast) as add-on to maintenance of inhaled corticosteroids in combi...
Phase 2
Jerez De La Frontera, Spain and 178 other locations
compared to omalizumab* To evaluate the effect of dupilumab on asthma control at Week 24 compared to omalizumab* To evaluate the safety of ...
Phase 4
Sevilla, Andalucia, Spain and 94 other locations
to assess efficacy and safety of Beltavac with polymerized extract of house dust mites in allergic Rhinoconjunctivitis associated or not with asthma...
Phase 3
Sevilla, Spain and 17 other locations
This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with CRSwNP.
Phase 3
Sevilla, Spain and 84 other locations
Clinical trials
Research sites
Resources
Legal